FISH, Myeloma, 17p-, rea 14q32 with Reflexes
Test Summary
N/A
Aliases
- N/A
Specimen Collection
Special Instructions
N/A
Preferred Specimen
3 mL bone marrow collected in a sodium heparin (green-top), (royal blue-top), or (lead-free tan-top) tube
Minimum Volume
1 mL
Instructions
1-3 mL bone marrow collected in a sodium heparin tube.
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. Do not reject.
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. Do not reject.
Patient Preparation
N/A
Storage
N/A
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: See instructions
- Refrigerated: See instructions
- Frozen: See instructions
Limitations
N/A
Other Acceptable Specimens
N/A
Unacceptable Specimens
N/A
Order Code
MYEREF
EPIC (Premier) Code
LAB5642
Includes
FISH, Myeloma, 17p-, rea 14q32 and FISH, Myeloma, Risk Assessment Panel
When the result for IGH rearrangement is positive during initial FISH analysis, the IGH Panel (MAFB, MAF, FGFR3, CCND1) will be performed at an additional charge (CPT code(s): 88271 (x8), 88275 (x4)).
This allows identification of high risk t(14;16) and t(14;20), intermediate risk t(4;14), and standard risk t(11;14).
Please note: Partial reports are issued when the sample is insufficient to perform all components of the FISH panel.
When the result for IGH rearrangement is positive during initial FISH analysis, the IGH Panel (MAFB, MAF, FGFR3, CCND1) will be performed at an additional charge (CPT code(s): 88271 (x8), 88275 (x4)).
This allows identification of high risk t(14;16) and t(14;20), intermediate risk t(4;14), and standard risk t(11;14).
Please note: Partial reports are issued when the sample is insufficient to perform all components of the FISH panel.
CPT Code
- 88271 (x4)
- 88275 (x2) for the FISH
- Myeloma
- 17p-
- rea 14q32 component - 88271 (x7)
- 88275 (x3) for the FISH
- Myeloma
- Risk Assessment Panel component
Billing Code
- 671086
- 671087
CPT Statement
Methodology
Fluorescence In Situ Hybridization (FISH)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Physician Attestation of Informed Consent
N/A
Testing Laboratory
Quest Diagnostics Nichols Institute
33608 Ortega Highway
San Juan Capistrano CA, 92675
33608 Ortega Highway
San Juan Capistrano CA, 92675
Department
N/A
Reference Range
See Laboratory Report
Setup Schedule / Expected Turnaround Time
Daily; Report available: 8 days
Specimen Collection
Special Instructions
N/A
Preferred Specimen
3 mL bone marrow collected in a sodium heparin (green-top), (royal blue-top), or (lead-free tan-top) tube
Minimum Volume
1 mL
Instructions
1-3 mL bone marrow collected in a sodium heparin tube.
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. Do not reject.
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. Do not reject.
Patient Preparation
N/A
Storage
N/A
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: See instructions
- Refrigerated: See instructions
- Frozen: See instructions
Limitations
N/A
Other Acceptable Specimens
N/A
Unacceptable Specimens
N/A
Billing
CPT Code
- 88271 (x4)
- 88275 (x2) for the FISH
- Myeloma
- 17p-
- rea 14q32 component - 88271 (x7)
- 88275 (x3) for the FISH
- Myeloma
- Risk Assessment Panel component
Billing Code
- 671086
- 671087
CPT Statement
Result Information
Methodology
Fluorescence In Situ Hybridization (FISH)
Testing Laboratory
N/A
Reference Range
See Laboratory Report
Setup Schedule / Expected Turnaround Time
Daily; Report available: 8 days